Related Experiment Video
Updated: Dec 21, 2025

Live Imaging to Study Microtubule Dynamic Instability in Taxane-resistant Breast Cancers
Published on: February 20, 2017
Gene Prioritization and Network Topology Analysis of Targeted Genes for Acquired Taxane Resistance by Meta-Analysis
Dongha Kim1, Young Seok Lee1, Jin Ki Kim1
1Department of Biochemistry, School of Medicine, Konkuk University, Seoul, Korea.
Abstract:
Network topology-based approaches prove to be highly efficient in addressing multifactorial phenomena such as acquired drug resistance in cancer. The aim of this study was to identify differentially expressed genes across multiple microarray datasets (meta-DEGs), to prioritize meta-DEGs to find the most promising genes linked to acquired taxane resistance (ATR), and to analyze the relevant biological networks using topology analysis. A total of 771 meta-DEGs were identified by performing a cross-platform meta-analysis of ATR-related microarray datasets. A gene prioritization method was used to simultaneously identify activated or deactivated genes on a co-expression map and protein-protein interaction (PPI) network. The top 10 prioritized genes in the gene co-expression and the top 1% highly ranked genes in the PPI network were identified. The selected meta-DEGs were used to construct biological networks, and topological analysis was performed using network centrality measures. Using integrative analyses, we identified ATR candidate genes, including several previously unidentified genes that were found to be associated with ATR. From the gene co-expression network, PRSS23 was the highest-ranking gene at local average connectivity measure and ADAM9 was ranked highest in other centralities. In protein interaction network, HSPA1A, ANXA1, and PA2G4 showed highest ranks in network centrality analyses. This study provides a comprehensive overview of the gene expression patterns associated with ATR. Furthermore, it presents a new approach to identification of unveiled candidate genes to ATR, using a gene prioritization method and network analysis.
Insights
This study identifies key genes involved in acquired taxane resistance (ATR) using network analysis of microarray data. It prioritizes candidate genes, offering new insights into cancer drug resistance mechanisms.
Area of Science:
- Oncology
- Bioinformatics
- Systems Biology
Background:
- Acquired drug resistance in cancer is a complex, multifactorial challenge.
- Network topology-based approaches offer powerful tools for dissecting such phenomena.
Purpose of the Study:
- To identify meta-differentially expressed genes (meta-DEGs) associated with acquired taxane resistance (ATR).
- To prioritize these meta-DEGs using gene prioritization methods and network topology analysis.
- To uncover novel candidate genes implicated in ATR.
Main Methods:
- Cross-platform meta-analysis of multiple microarray datasets to identify 771 meta-DEGs.
- Gene prioritization on co-expression and protein-protein interaction (PPI) networks.
- Network construction and topological analysis using centrality measures.
Main Results:
- Identified top-ranked genes in co-expression (PRSS23, ADAM9) and PPI networks (HSPA1A, ANXA1, PA2G4).
- Uncovered several novel candidate genes associated with ATR.
- Demonstrated the utility of integrative network analysis for identifying ATR-related genes.
Conclusions:
- This study provides a comprehensive gene expression overview linked to ATR.
- The proposed gene prioritization and network analysis approach effectively identifies novel ATR candidate genes.
- Findings contribute to a deeper understanding of the molecular mechanisms underlying cancer drug resistance.
More Related Videos
06:44Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel
Published on: September 8, 2017
08:59Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
Published on: December 11, 2017
Related Concept Videos
Treatment Resistant Cancers
Targeted Cancer Therapies
There are several types of targeted therapies against...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...